ArticleAlzheimer's research & therapy2025

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.

Clemente Humberto Zúñiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.